circRNA 합성 시장 규모, 점유율, 성장 분석 : 제품 유형별, 합성 방법별, 용도별, 최종사용자별, 규모별, 유통 채널별, 지역별 - 산업 예측(2026-2033년)

Global Circrna Synthesis Market size was valued at USD 420.0 Million in 2024 and is poised to grow from USD 498.12 Million in 2025 to USD 1949.9 Million by 2033, growing at a CAGR of 18.6% during the forecast period (2026-2033).

The global circular RNA (circRNA) synthesis market is rapidly evolving within the nucleic-acid therapeutics sector, spurred by the increasing recognition of circRNA's stability and regulatory functions. Following advancements in high-throughput sequencing that uncovered numerous endogenous circRNAs, biotech firms are now prioritizing synthetic platforms, offering enzymatic kits for circRNA production. This transition emphasizes the market's significance, transforming biological insights into viable pipelines for diagnostics and therapeutics like vaccines and gene editing. The availability of synthesis kits supports investment in circRNA-based therapies, particularly in vaccine development due to circRNA's resilience compared to mRNA. Additionally, AI-driven automation is enhancing efficiency and reducing development timelines, driving accelerated investment and market growth as the industry adapts to advanced manufacturing and quality monitoring technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circrna Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Circrna Synthesis Market Segments Analysis

Global circrna synthesis market is segmented by product type, synthesis method, application, end user, scale, distribution channel and region. Based on product type, the market is segmented into circRNA Synthesis Kits, circRNA Reagents and Custom circRNA Synthesis Services. Based on synthesis method, the market is segmented into In Vitro Transcription, Enzymatic Circularization and Chemical Synthesis. Based on application, the market is segmented into Drug Discovery, Vaccine Development, Basic Research and Others. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes and Others. Based on scale, the market is segmented into Research Grade and GMP Grade. Based on distribution channel, the market is segmented into Direct Sales, Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Circrna Synthesis Market

The Global Circrna Synthesis market is experiencing significant growth due to advancements in synthetic biology techniques, including enzymatic ligation and automated RNA assembly. These developments allow researchers to create circular RNAs with greater accuracy and efficiency, streamlining experimental workflows and minimizing resource consumption. As a result, there's an increasing adoption of these technologies in both academic and industrial laboratories. The ability to produce high-quality circRNA constructs enhances interest in therapeutic research, diagnostic innovations, and functional studies, thereby broadening the scope of applications. Furthermore, these improvements reduce entry barriers for smaller biotech companies, promoting competitive innovation and speeding up commercialization processes.

Restraints in the Global Circrna Synthesis Market

The production of high-purity circular RNAs necessitates the use of specialized enzymes, tailored reaction conditions, and thorough purification processes, which significantly increase manufacturing costs. These financial pressures pose challenges for smaller organizations seeking to enter the market, ultimately affecting pricing strategies for end users, especially in academic environments where budgets are tight. As a result, the economic barriers hinder widespread adoption of these innovative technologies and may delay the conversion of promising circular RNA advancements into market-ready products, restricting overall market growth. Furthermore, these financial constraints deter long-term commitments to research and development efforts in the field.

Market Trends of the Global Circrna Synthesis Market

The global circRNA synthesis market is experiencing a transformative shift driven by advancements in artificial intelligence. AI platforms are enhancing the efficiency of circRNA synthesis processes by automating critical tasks such as sequence optimization and off-target analysis. This technological integration allows researchers to significantly reduce the time required for experimental iterations, fostering quicker development cycles. High-throughput screening combined with machine learning facilitates the rapid identification of viable constructs, promoting collaboration between biotech firms and computational experts. As a result, this trend not only accelerates the journey of therapeutic candidates to market but also encourages investments in innovative disease targets and exploration of clinical applications.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global CircRNA Synthesis Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• circRNA Synthesis Kits
• circRNA Reagents
• Custom circRNA Synthesis Services

Global CircRNA Synthesis Market Size by Synthesis Method & CAGR (2026-2033)

• Market Overview
• In Vitro Transcription
• Enzymatic Circularization
• Chemical Synthesis

Global CircRNA Synthesis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Vaccine Development
• Basic Research
• Others

Global CircRNA Synthesis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutes
• Others

Global CircRNA Synthesis Market Size by Scale & CAGR (2026-2033)

• Market Overview
• Research Grade
• GMP Grade

Global CircRNA Synthesis Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors
• Others

Global CircRNA Synthesis Market Size & CAGR (2026-2033)

• North America (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriLink BioTechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VectorBuilder Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCat GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ST Pharm Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aldevron LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACROBiosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (Azenta)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Synthesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations